Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,979 | -7,343 | -6,252 | -2,223 | -10,418 |
| Depreciation Amortization | 189 | 139 | 90 | 43 | 166 |
| Accounts receivable | -169 | -146 | -8 | -16 | -3 |
| Accounts payable and accrued liabilities | 294 | 212 | 27 | 42 | 19 |
| Other Working Capital | 29 | -60 | -283 | -476 | 515 |
| Other Operating Activity | 407 | 1,316 | 2,243 | 313 | 3,291 |
| Operating Cash Flow | $-8,230 | $-5,883 | $-4,183 | $-2,318 | $-6,430 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 621 | -924 | -1,920 | -4,928 | 3,423 |
| PPE Investments | -106 | -94 | -35 | N/A | -171 |
| Investing Cash Flow | $515 | $-1,018 | $-1,955 | $-4,928 | $3,252 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,528 | 7,528 | 7,528 | 7,528 | 2,349 |
| Other Financing Activity | -149 | -22 | -22 | -10 | 0 |
| Financing Cash Flow | $7,379 | $7,506 | $7,506 | $7,519 | $2,349 |
| Beginning Cash Position | 884 | 884 | 884 | 884 | 1,714 |
| End Cash Position | 548 | 1,489 | 2,252 | 1,157 | 884 |
| Net Cash Flow | $-337 | $605 | $1,368 | $273 | $-829 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,230 | -5,883 | -4,183 | -2,318 | -6,430 |
| Capital Expenditure | -106 | -94 | -35 | N/A | -171 |
| Free Cash Flow | -8,337 | -5,976 | -4,218 | -2,318 | -6,601 |